# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4780117 | LacB-4E-BP1 | Activity | 0 | ALA4773327 | Active | Homo sapiens | |||||
2. | ALA4780117 | LacB-4E-BP1 | t1/2 | < | 5 | min | ALA4773326 | hr | ||||
3. | ALA4780117 | LacB-4E-BP1 | Activity | 0 | ALA4773325 | Not Active | Homo sapiens | |||||
4. | ALA4780117 | LacB-4E-BP1 | Activity | 0 | ALA4773324 | Not Active | Homo sapiens | |||||
5. | ALA4780117 | LacB-4E-BP1 | Activity | 0 | ALA4773323 | Not Active | Homo sapiens | |||||
6. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773322 | Dose-dependent effect | % | Homo sapiens | ||||
7. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773321 | Dose-dependent effect | % | Homo sapiens | ||||
8. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773320 | Dose-dependent effect | % | Homo sapiens | ||||
9. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773319 | Dose-dependent effect | % | Homo sapiens | ||||
10. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773318 | Dose-dependent effect | % | Homo sapiens | ||||
11. | ALA4780117 | LacB-4E-BP1 | INH | 0 | ALA4773317 | Dose-dependent effect | % | Homo sapiens | ||||
12. | ALA4780117 | LacB-4E-BP1 | Drug uptake | = | 20 | % | ALA4773316 | % | ||||
13. | ALA4780117 | LacB-4E-BP1 | Q50 | = | 1.5 | uM | ALA4773315 | uM | ||||
14. | ALA4780117 | LacB-4E-BP1 | Activity | 0 | ALA4773314 | Active | Homo sapiens | |||||
15. | ALA4780117 | LacB-4E-BP1 | Kd | = | 2.2 | nM | ALA4773313 | 8.66 | nM | Homo sapiens | ||
16. | ALA4780117 | LacB-4E-BP1 | Kd | = | 6.9 | 10^-3/s | ALA4773312 | 10^-3/s | Homo sapiens | |||
17. | ALA4780117 | LacB-4E-BP1 | Ka | = | 3.1 | 10^-6/M/s | ALA4773311 | 10^-6/M/s | Homo sapiens | |||
18. | ALA4780117 | LacB-4E-BP1 | IC50 | = | 6.5 | nM | ALA4773310 | 8.19 | nM | Homo sapiens |